Founded in 2013, Dongsheng Chiral (Shanghai) Pharmaceutical Technology Co., Ltd. (Former Shanghai Yaocheng Pharmaceutical Co., Ltd.), located in the Lin-gang Special Area of Shanghai Pilot Free Trade Zone (national-level), is a high-tech enterprise greatly supported by Lin-gang Special Area. At present, a small molecule drugs process R&D center has been operated in Wujiang District, Suzhou, while a production base for key intermediates of Class I innovative drugs has been put into operation in Lanzhou New Area, Gansu Province, and a high-level R & D center has been built in the Western Medicine Valley of Lanzhou. The Company focuses on the development of high technical barriers, difficulty and complex chiral pharmaceutical API and intermediate products, explores innovative synthesis pathways by comprehensive use of asymmetric catalysis, chiral induction, enzyme catalysis, salting-out crystallization and other technologies to greatly optimize the production process of new pharmaceutical intermediates. It provides innovative pharmaceutical companies with one-stop services for the whole cycle of new pharmaceutical research and development, process optimization, test site and commercial customized production.

Founded in 2013, Suzhou Chiral Pharmaceuticals Technology Co., Ltd. located in Hight-Tech Pack of Suzhou Wujiang District and invested by Dongsheng Chiral (Shanghai) Pharmaceuticals Technology Co., Ltd., is a high-end service-oriented technology enterprise committed to the outsourcing research and development of small molecule chemical innovative drugs. The laboratory is equipped with international standard analytical equipment including high-performance liquid chromatography, liquid mass spectrometer and high-performance liquid phase purifier, providing comprehensive and accurate data support and quality assurance for drugs development through multiple testing methods; providing a full range of drugs development services from preclinical drug discovery to commercial production for domestic and foreign innovative drug companies.

Founded in 2018, Lanzhou Kairuide Pharmaceuticals Technology Co., Ltd. Is located in the Western Medicine Valley of Lanzhou National Industrial Base, Lanzhou New District, Gansu. It is a CDMO (Contract Development Manufacture Organization) invested by Dongsheng Chiral (Shanghai) Pharmaceuticals Technology Co., Ltd. The Company focuses on the development of high technical barriers, difficulty and complex chiral pharmaceutical API and intermediate products, explores innovative synthesis pathways by comprehensive use of asymmetric catalysis, chiral induction, enzyme catalysis, salting-out crystallization and other technologies to greatly optimize the production process of new pharmaceutical intermediates.

Founded in 2019, Lanzhou Yaocheng Pharmaceuticals Technology Co., Ltd. is located in Zone A of the Specialized, Refined, Differential and Innovational (SRDI) Industrial Park of Lanzhou New Area. It is a high-tech enterprise invested by Dongsheng Chiral (Shanghai) Pharmaceuticals Technology Co., Ltd., which integrates the research, development and production of chemicals and pharmaceutical intermediates. The production base in Lanzhou is equipped with all kinds of advanced production equipment and a large number of experienced technicians. International advanced production equipment such as porcelain-lined reactors, centrifuges and filter presses equipped with semi-automatic DCSM integrated control system (rise and drop of temperature, constant temperature, pressure control, etc.) can carry out many different types of reactions: asymmetric catalysis, metal catalysis, high temperature, high pressure, low temperature, etc. It can produce a variety of innovative intermediate products.

Shanghai Yaokang Pharmaceuticals Technology Co., Ltd. was established in 2020, located in Life Science & Tech Park (under preparation) in Fengxian Park of Shanghai Lingang Special Area (national free trade zone).